98%
921
2 minutes
20
Background: The giant keyhole limpet is a gastropod mollusk (Fissurella superfamily) that is endemic to the eastern Pacific coast from southern California, USA, to Baja California Sur, Mexico. is socioeconomically important as it produces a potent immune-stimulating protein, called Keyhole Limpet Hemocyanin, which is extracted in vivo and utilized for vaccine development. However, ecological studies are scarce and genetic knowledge of the species needs to be improved. Our objectives were to assemble and annotate the mitogenome of , and to assess its phylogenetic relationships with other marine gastropods and to evaluate its population genetic diversity and structure.
Methods: Samples were collected for mitogenome assembly ( = 3) spanning its geographic range, Puerto Canoas (PCA) and Punta Eugenia (PEU), Mexico, and California (CAL), USA. Total DNA was extracted from gills sequenced using Illumina paired-end 150-bp-read sequencing. Reads were cleaned, trimmed, assembled , and annotated. In addition, 125 samples from eight locations were analyzed for genetic diversity and structure analysis at the and genes.
Results: The mitogenomes had lengths of 16,788 bp (PCA) and 16,787 bp (PEU) and were composed of 13 protein-coding regions, 22 tRNAs, two rRNAs, and the D-Loop region. In terms of phylogeographic diversity and structure, we found a panmictic population that has experienced recent demographic expansion with low nucleotide diversity (0.002), high haplotypic diversity (0.915), and low (0.047).
Conclusions: Genetic insights into the giant keyhole limpet provides tools for its management and conservation by delimiting fishing regions with low genetic diversity and/or genetically discrete units.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507411 | PMC |
http://dx.doi.org/10.3390/genes15101303 | DOI Listing |
J Pharmacol Exp Ther
July 2025
Pharmaceutical Science Department, Chugai Pharmaceutical Co, Ltd, Yokohama, Japan.
The administration of peptide drugs can induce the generation of anti-drug antibodies (ADAs), potentially leading to unwanted effects such as reduced drug efficacy, which is often seen with therapeutic monoclonal antibodies. However, the influence of ADAs on the pharmacokinetic and pharmacodynamic properties of cell-permeable middle molecules remains unclear. This study investigated ADA impacts using AP2151, a middle molecule cyclic peptide with high cell membrane permeability.
View Article and Find Full Text PDFToxics
July 2025
Division of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27560, USA.
The broad-spectrum insect growth regulator (IGR) and insecticide 2-((1-(4-Phenoxyphenoxy)propan-2-yl)oxy)pyridine (MPEP; also known as pyriproxyfen) is increasingly being used to address public health programs for vector control, initiated by the spread of Zika virus in 2015-2016. While considered relatively safe for humans under normal conditions, limited toxicology data are available. Current studies were undertaken to address the data gap regarding potential immunotoxicity of MPEP, with particular emphasis on host resistance to viral infection.
View Article and Find Full Text PDFClin Pharmacol Ther
July 2025
Centre for Human Drug Research, Leiden, The Netherlands.
Novel compounds targeting the adaptive immune system are commonly initially investigated in healthy volunteers (HV). HV frequently lack constitutively expressed drug-target engagement biomarkers, complicating the evaluation of pharmacological activity. The keyhole limpet hemocyanin (KLH) neo-antigen challenge elicits a controlled immune response in HV and is a potential model for investigating compounds targeting the adaptive immune system.
View Article and Find Full Text PDFJ Immunol Methods
September 2025
Animal Health Laboratory, ICAR-National Research Centre on Pig, Guwahati 781131, Assam, India.
Classical Swine Fever (CSF) is a highly contagious viral disease that causes substantial economic losses in the swine industry. Timely detection of CSFV infection is essential for effective disease control; however, current antibody-based diagnostic methods are limited due to the delayed host immune response. In this study, we developed a novel peptide-based lateral flow assay (LFA) targeting the E2 antigen of the Classical Swine Fever Virus (CSFV) to enable rapid and field-deployable detection.
View Article and Find Full Text PDFInt J Toxicol
September 2025
Department of Biological Systems Engineering, College of Engineering & College of Agricultural and Life Sciences, Virginia Tech, Blacksburg, VA, USA.
A nanoparticle-based immunization strategy offers a promising treatment for opioid use disorder (OUD). This study tested the safety of subunit keyhole limpet hemocyanin-loaded lipid-PLGA hybrid nanoparticles (sKLH-hNPs) as a nanocarrier for OUD vaccine in adult male BALB/c mice by subcutaneous administration at an effective low dose (60 μg) and a dose 5-fold higher (300 μg), with cohorts of animals (n = 10/group, including controls) observed and evaluated for behavioral changes. At 3, 14, 28, and 56 days after dosing, mice (n = 3/dose) were sacrificed, and serum was collected for evaluation of electrolytes, minerals, proteins, liver function, renal function, and energy metabolism.
View Article and Find Full Text PDF